Ronald Crystal

Founder & Chief Scientific Adviser at LEXEO Therapeutics

Ronald Crystal is a physician-scientist and pioneer in In vivo gene therapy. He is a Professor and Chairman, Department of Genetic Medicine, Weill Cornell Medical College, previously Chief, Pulmonary Branch, NHLBI. He also directs the Weill Cornell Belfer Gene Therapy Core facility, with 45 faculty/staff, including viral vector, pre-clinical translation, toxicology, regulatory and GMP manufacturing expertise.

Dr. Crystal has 14 approved gene therapy investigational new drug applications with experience in CNS, cardiac, pulmonary and liver human gene therapy.

Dr. Crystal is the founder/co-founder of several gene therapy companies including GenVec, Adverum and XyloCor.

Timeline

  • Founder & Chief Scientific Adviser

    Current role